Prolaris Gets Favorable Final Local Coverage Decision
Noridian has issued a positive LCD for the Prolaris prostate cancer test by Myriad Genetics.
Read MoreSearch Results for: prostate cancer
Opko Health to Acquire Bio-Reference Laboratories
The transaction, expected for completion later this year, is valued at approximately $1.47 billion.
Read More
Liquid Biopsies: Doing More with Less
An emerging method of molecular analysis holds significant potential for profiling the tumors where the biomarkers originated, and thereby improving the diagnosis and treatment of cancer and other diseases.
Read More
Inside Track: Molecular Markers for Colorectal Cancer
CLP speaks with Antonia R. Sepulveda, MD, PhD, FASCP, FCAP, of Columbia University, about a forthcoming clinical practice guideline for the use of molecular marker testing in patients with primary or metastatic colorectal carcinoma.
Read More
Pathology under Fire
Breast pathology experts share their views about a controversial JAMA study that has raised public anxiety and professional frustration.
Read More